Treatment for Chronic Cough
Begin immediately with a first-generation antihistamine/decongestant combination (such as dexbrompheniramine plus sustained-release pseudoephedrine or azatadine plus sustained-release pseudoephedrine) as the most effective first-line treatment, targeting upper airway cough syndrome (UACS), which is the most common cause of chronic cough in adults. 1, 2
Initial Mandatory Steps Before Treatment
- Discontinue ACE inhibitors immediately if the patient is taking them, as no patient with troublesome cough should continue these medications 1
- Encourage smoking cessation as it is one of the commonest causes of persistent cough and cessation leads to significant symptom remission 1
- Obtain chest radiograph and spirometry as mandatory baseline investigations to rule out serious pathology 1, 3, 4
- Assess cough severity using visual analogue scores or cough-specific quality of life questionnaires 1, 4
Systematic Treatment Algorithm
Phase 1: Treat Upper Airway Cough Syndrome (Most Common Cause)
- Start with first-generation antihistamine/decongestant combination for 1-2 weeks 1, 2
- To minimize sedation, begin with once-daily dosing at bedtime for a few days before increasing to twice-daily therapy 2
- Most patients will see improvement within days to 2 weeks 2
- Common side effects include dry mouth and transient dizziness; monitor for insomnia, urinary retention, jitteriness, tachycardia, worsening hypertension, and increased intraocular pressure in glaucoma patients 2
If no improvement after 1-2 weeks:
- Add intranasal corticosteroids (fluticasone 100-200 mcg daily) for a 1-month trial 1, 2
- Consider ipratropium bromide nasal spray (42 mcg per spray, 2 sprays per nostril 4 times daily) as an alternative for patients with contraindications to decongestants 2
- Add high-volume saline nasal irrigation (150 mL) to mechanically remove secretions 2
Phase 2: Treat Asthma/Eosinophilic Bronchitis (If UACS Treatment Fails)
- Perform bronchial provocation testing (methacholine challenge) in patients with normal spirometry to assess for bronchial hyperresponsiveness 1, 3
- If testing is unavailable, conduct a 2-week trial of oral corticosteroids (e.g., prednisone); cough is unlikely to be due to eosinophilic airway inflammation if there is no response 1, 3
- A negative methacholine test excludes asthma but does not rule out a steroid-responsive cough 1
- Initiate inhaled corticosteroids or bronchodilators based on clinical response 5, 6
Phase 3: Treat Gastroesophageal Reflux Disease (If Above Treatments Fail)
- Initiate intensive acid suppression with proton pump inhibitors (omeprazole 20-40 mg twice daily before meals) and alginates for a minimum of 3 months 1, 4
- GERD-associated cough may occur in the absence of gastrointestinal symptoms, making it a common reason for treatment failure when not considered 1
- Improvement in cough from GERD treatment may take up to 3 months 2
- Empirical treatment should be offered before oesophageal testing 1
Recognition of Multifactorial Cough
- In 92-100% of nonsmoking patients not using ACE inhibitors with normal chest radiographs, one, two, or all three conditions (UACS, asthma, GERD) explain chronic cough 1
- Maintain all partially effective treatments rather than discontinuing them prematurely, as multiple causes often coexist 2
- Treatment effects should be formally quantified using validated measures 1, 4
When to Pursue Advanced Investigation
- Consider high-resolution computed tomography if other targeted investigations are normal and empiric treatments have failed 1, 4
- Perform bronchoscopy in patients with suspected foreign body inhalation 1
- Obtain induced sputum for eosinophil count after exclusion of other common causes, as sputum eosinophilia (>3%) has important treatment implications 1
- Consider nonasthmatic eosinophilic bronchitis (NAEB), which presents with cough, eosinophilic infiltration, normal spirometry, lack of bronchial hyperresponsiveness, and responds to corticosteroid treatment 1
Specialist Referral Criteria
- Refer to a specialist cough clinic when chronic cough remains undiagnosed after systematic evaluation of UACS, asthma, eosinophilic bronchitis, and GERD 1, 4
- Chronic cough should only be considered idiopathic following thorough assessment at a specialist cough clinic 1
- For truly refractory chronic cough, consider multimodality speech pathology therapy or gabapentin (starting at 300 mg once daily with dose escalation) 2, 7, 6, 8
Critical Pitfalls to Avoid
- Never overlook "silent" presentations: UACS, asthma, and GERD can each present with cough as the only manifestation without typical associated symptoms 1, 2
- Approximately 20% of patients have "silent" postnasal drip with no obvious symptoms yet still respond to treatment 2
- Newer-generation antihistamines are ineffective for non-allergic causes of UACS; first-generation antihistamines are superior due to their anticholinergic properties 2
- Failure to consider GORD as a cause is a common reason for treatment failure 1
- Inadequate treatment duration: GERD requires at least 3 months of intensive acid suppression for proper evaluation 1
- Never use topical nasal decongestants (oxymetazoline, xylometazoline) for more than 3-5 consecutive days due to risk of rhinitis medicamentosa 2